Latest news

Journal newsletter sent to subscribers in week 36, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 34, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 29, 2009. Register to receive future newsletters. 

Read the call for papers from Editor in Chief Dr Marc Basson

Journal newsletter sent to subscribers in week 25, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 23, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 19, 2009. Register to receive future newsletters.

Cancer Growth and Metastasis formally launched

Individuals wishing to join the editorial board may register here

Peer reviewers are sought. Click here to apply or to update your details.

Cancer Growth and Metastasis accepted for indexing by CAS

Cancer Growth and Metastasis Introductory Editorial published

Journal overview

Aims and scope:

Cancer Growth and Metastasis is an open access, peer reviewed journal which covers all aspects of the growth, invasion and spread of cancer within the body. Research at both the basic and applied levels, and on the molecular, cellular or organ levels, is of interest. Mutation, carcinogenesis, proliferation, tumour formation and metastasis are examples of the topics included.

Submissions on oncological and radiological treatment of cancer will also be considered.

Indexing:

This journal is indexed by:

• OAIster
  

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.   

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

Call for papers:

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
  
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.

Editor in Chief profile

Dr Marc Basson (MD, PhD, MBA) is Professor and Chair of the Department of Surgery, Michigan State University College of Human Medicine, USA. He has a strong background in both basic and clinical cell research. Prior to these appointments Dr Basson was Assistant Professor, then Associate Professor, at Yale University, where he received his MPhil and PhD in Experimental Pathology. He has also had experience working as an Attending Surgeon at Yale New Haven Hospital (including 5 years in the Division of Surgical Oncology), John D. Dingell VA Medical Centre and West Haven VA. At the latter he was also Chief of Surgical Endoscopy and Director of the Colorectal Clinics during his time there.

Dr Basson has published over 190 articles and contributed to 10 edited books, as well as editing 3 books himself. He is currently working on several funded projects, including the effect of pressure on colon cancer cell adhesion. He also has many responsibilities in peer reviewing, consulting, committees, and professional organizations in surgery and oncology.

>> Dr Basson's latest call for papers

Editorial Board

David Cory Adamson, MD, PhD, MPH, MHSc
Assistant Professor, Department of Surgery, School of Medicine, Duke University, Durham, NC, USA

Daniela Bota, MD, PhD
Assistant Professor, Department of Neurology, Neurosurgery and Hematology-Oncology, The Cancer Centre, University of California, Irvine, CA, USA

Weibo Cai, PhD
Assistant Professor, Radiology, University of Wisconsin, Madison, WI, USA

Barbara Conley, MD
Professor and Chief, Division of Hematology/Oncology, Michigan State University, East Lansing, MI, USA

Graeme Dougherty, PhD
Professor, Department of Radiation Oncology, University of Arizona, Tucson, AZ, USA

Robert Hardy, PhD
Associate Professor, Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

Zhenyu Ji, MD PhD
Translational Research Fellow, Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA

Zibo Li, PhD
Assistant Professor, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Liang Schweizer, PhD
Principal Scientist, Research and Development, Bristol Myers Squibb, Princeton, NJ, USA

Gene P Siegal, MD, PhD
Mowry Professor and Executive Vice-Chair of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

Douglas Spitz, PhD
Professor and Director, Free Radical and Radiation Biology Program, Radiation Oncology, University of Iowa, Iowa City, IA, USA

Sanjay K Srivastava, PhD
Associate Professor, Pharmaceutical Sciences, Texas Tech University Health Sciences Centre, Amarillo, TX, USA

Martin Sebastian Staege, PhD
Head of Laboratory, Children's Cancer Research Centre, Department of Pediatrics, Martin-Luther-University, Halle, Germany 

Join an editorial board or update your details:

Related journals